Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOSAIc: Observational Study of Insulin Therapy Progression in Type 2 Diabetes
jRCT1080221979Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Primary endpoint: Challenges in progression of insulin therapy. Started Dec 2012; status: recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080221979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221979.